Ajinomoto 
Welcome,         Profile    Billing    Logout  
 1 Product   2 Diseases  1 Product   3 Trials   102 News 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
budesonide rectal foam / Generic mfg.
2009-015077-12: The use of corticosteroids (Budenofalk) as a chemopreventative agent in ulcerative colitis associated neoplasia

Ongoing
4
50
Europe
Budenofalk rectal foam, Budenofalk 2mg rectal foam, Budenofalk 2mg rectal foam
University Hospital Birmingham NHS Foundation Trust
chronic ulcerative colitis
 
 
NCT05976802: Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis

Not yet recruiting
4
100
NA
High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching placebo rectal foam
Bausch Health Americas, Inc.
Ulcerative Colitis
06/25
06/25
2016-001921-15: Novel budesonide suppository vs. budesonide foam in acute ulcerative proctitis.

Ongoing
3
576
Europe
Budenofalk® suppositories (BUS), Budenofalk® 2 mg foam, Suppository, Rectal foam, Budenofalk® 2 mg foam
Dr. Falk Pharma GmbH, Dr. Falk Pharma GmbH
Acute Ulcerative Proctitis, Acute Ulcerative Proctitis - Inflammation of the Rectum, Diseases [C] - Digestive System Diseases [C06]
 
 
Goofice (elobixibat) / Ipsen
R-LODD, NCT05165199: Elobixibat for Chronic Constipation Without Defecation Desire

Recruiting
4
40
Japan
Elobixibat 10mg
Yokohama City University
Chronic Constipation
09/22
03/23
NCT05703464: Elobixibat for Chronic Constipation Without Defecation Desire

Terminated
4
40
Japan
Elobixibat 10mg
International University of Health and Welfare
Chronic Constipation
03/23
03/23
TANK-27, NCT04784780: Long-term Elobixibat for Chronic Constipation

Recruiting
4
100
Japan
Elobixibat 10mg, AJG533 10 mg, Placebo, AJG533 placebo
Yokohama City University
Chronic Constipation
06/23
11/23
NCT05895877: Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation

Recruiting
3
351
RoW
Goofice®, Goofice® Placebo
Synmosa Biopharma Corp.
Constipation
09/23
09/23
NCT06436833: Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Glycol Regimen

Recruiting
N/A
360
RoW
2-Liter polyethylene glycol plus elobixibat, 4-Liter polyethylene glycol
Rajavithi Hospital
Bowel Preparation Solution, Colonoscopy
11/24
12/24
APY0201 / Ajinomoto
No trials found
Lentinon (lentinan) / Ajinomoto
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
budesonide rectal foam / Generic mfg.
2009-015077-12: The use of corticosteroids (Budenofalk) as a chemopreventative agent in ulcerative colitis associated neoplasia

Ongoing
4
50
Europe
Budenofalk rectal foam, Budenofalk 2mg rectal foam, Budenofalk 2mg rectal foam
University Hospital Birmingham NHS Foundation Trust
chronic ulcerative colitis
 
 
NCT05976802: Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis

Not yet recruiting
4
100
NA
High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching placebo rectal foam
Bausch Health Americas, Inc.
Ulcerative Colitis
06/25
06/25
2016-001921-15: Novel budesonide suppository vs. budesonide foam in acute ulcerative proctitis.

Ongoing
3
576
Europe
Budenofalk® suppositories (BUS), Budenofalk® 2 mg foam, Suppository, Rectal foam, Budenofalk® 2 mg foam
Dr. Falk Pharma GmbH, Dr. Falk Pharma GmbH
Acute Ulcerative Proctitis, Acute Ulcerative Proctitis - Inflammation of the Rectum, Diseases [C] - Digestive System Diseases [C06]
 
 
Goofice (elobixibat) / Ipsen
R-LODD, NCT05165199: Elobixibat for Chronic Constipation Without Defecation Desire

Recruiting
4
40
Japan
Elobixibat 10mg
Yokohama City University
Chronic Constipation
09/22
03/23
NCT05703464: Elobixibat for Chronic Constipation Without Defecation Desire

Terminated
4
40
Japan
Elobixibat 10mg
International University of Health and Welfare
Chronic Constipation
03/23
03/23
TANK-27, NCT04784780: Long-term Elobixibat for Chronic Constipation

Recruiting
4
100
Japan
Elobixibat 10mg, AJG533 10 mg, Placebo, AJG533 placebo
Yokohama City University
Chronic Constipation
06/23
11/23
NCT05895877: Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation

Recruiting
3
351
RoW
Goofice®, Goofice® Placebo
Synmosa Biopharma Corp.
Constipation
09/23
09/23
NCT06436833: Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Glycol Regimen

Recruiting
N/A
360
RoW
2-Liter polyethylene glycol plus elobixibat, 4-Liter polyethylene glycol
Rajavithi Hospital
Bowel Preparation Solution, Colonoscopy
11/24
12/24
APY0201 / Ajinomoto
No trials found
Lentinon (lentinan) / Ajinomoto
No trials found

Download Options